Practice Perfection.

Dr. Jacques Zaneveld is a professional scientist and entrepreneur. Half of his early life was spent on a boat in the South Pacific, while the other half was spent in Corvallis, Oregon. Traveling the world instilled him with a sense of wonder and curiosity that fuels his work to this day.

Trained as a scientist, Dr. Jacques Zaneveld has published numerous scientific papers, and obtained funding for his work from the National Eye Institute, National Library of Medicine, the CIBR center, and the National Science Foundation. Originally, 3D printing was a hobby, but he quickly realized its potential to revolutionize medicine and science.

Jacques founded Lazarus 3D to help scientists and clinicians by providing them with 3D printing tools and techniques.

Cheri Waddell, Sr. Clinical Program Manager for Pre-Sure at Lazarus 3D, is a highly-experienced Health Administrator with an extensive background in onboarding new employees, training existing employees, auditing clinic operations, establishing a budget, and reviewing treatment plans. She has served as an outstanding Operations Manager for healthcare organizations in her previous roles, where she worked closely with surgeons to provide high-quality health care to patients. Cheri is an invaluable team leader and a strong advocate of Lazarus 3D's mission to bring the best technologies that drive the quality of care and outcomes to the global healthcare community. By working with healthcare providers and fostering collaborations and unity, Cheri is committed to increasing Pre-Sure's impact on the care of patients.

At Lazarus 3D, Dr. Shalash concentrates on advancing patient-specific medical devices through innovative R&D and collaborative work with leaders in healthcare. As a biomedical engineer, Dr. Shalash spent his career developing innovative solutions to enable cryopreservation of intervetebral discs and cartilage tissue from patients. Additionally, his work utilizing finite element analysis and MR imaging led to the development of an ML driven approach to determining the microenvironment in the intervertebral discs which has applications in guiding stem cell therapy treatments. As a scientist and entrepreneur, Dr. Shalash is very excited about the future of surgical care, where advances in medical imaging, AI, automation and 3D printing will drive a new standard of care where patient treatment is always delivered with confidence.

Nancy's extensive background spans executive leadership roles in both for-profit companies and nonprofit entities. Before joining Lazarus 3D, Nancy served as the COO of UbiVac, Sedia Biosciences Corp, Yecuris Corporation as well as EIR at ONAMI. Her diverse expertise in medical devices, in-vitro diagnostics, immunotherapies, and image-guided surgical technologies is extensive and brings a depth of understanding and strategic vision to our operations.

Reflecting on her new role, Nancy shares, "I am incredibly excited to lead the next chapter of growth at Lazarus 3D. Our commitment to revolutionizing patient safety and outcomes in surgical care is a critical mission that I am proud of. I'm looking forward to collaborating with this talented team and making a tangible impact in healthcare."